Publication | Open Access

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial

Radiation MedicineRadiation TherapyMedicineBrachytherapyLate Toxicity ResultsOncologyRadiation OncologyTreatment VerificationPhase 3RadiologyHealth Sciences